A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection
Epistemonikos ID: 810f3f09d5621ad9d159ef2ecf4d54cf75080611
First added on: Aug 28, 2025